Literature DB >> 8526832

The effect of altitude pre-acclimatization on acute mountain sickness during reexposure.

T P Lyons1, S R Muza, P B Rock, A Cymerman.   

Abstract

BACKGROUND: Acclimatization to high altitude appears to prevent acute mountain sickness (AMS), as evidenced by a decline in AMS symptoms as acclimatization progresses. HYPOTHESIS: We hypothesized that partial retention of acclimatization would attenuate the incidence and/or severity of AMS upon reinduction to altitude.
METHODS: To test this hypothesis 6 male lowlanders returned to sea level after the acclimatizing of the 16 d at 4300 m (HA). After 8 d at sea level (PA), they were reexposed to 4300 m in a hypobaric chamber for 30 h (RA). AMS symptom severity was determined by the AMS-cerebral (AMS-C) scores calculated from the daily administration of the Environmental Symptoms Questionnaire during HA and RA.
RESULTS: The mean AMS-C scores were reduced from 0.6 on HA day 1 (HA1) to 0.1 during RA (p < 0.05). Four subjects were "sick" (AMS-C > 0.7) during HA1, while only one was "sick" during RA. The % oxyhemoglobin, hemoglobin concentration and hematocrit were higher during RA compared to HA1.
CONCLUSIONS: These results suggest that the retention of acclimatization after 8 d at low altitude is sufficient to attenuate AMS upon reinduction to high altitude.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8526832

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  8 in total

1.  Acclimatisation in trekkers with and without recent exposure to high altitude.

Authors:  Meaghan J MacNutt; Paul B Laursen; Shiksha Kedia; Maniraj Neupane; Parash Parajuli; Jhapindra Pokharel; A William Sheel
Journal:  Eur J Appl Physiol       Date:  2012-01-18       Impact factor: 3.078

2.  Factors affecting a climber's ability to ascend Mont Blanc.

Authors:  G Tsianos; L Woolrich-Burt; T Aitchison; A Peacock; M Watt; H Montgomery; I Watt; S Grant
Journal:  Eur J Appl Physiol       Date:  2005-10-19       Impact factor: 3.078

Review 3.  Airline chair-rest deconditioning: induction of immobilisation thromboemboli?

Authors:  John E Greenleaf; Nancy J Rehrer; Stanley R Mohler; David T Quach; David G Evans
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

4.  The Effect of Path and Beginning Time of Ascending on Incidence of Acute Mountain Sickness around Mount Damavand in Iran (5671 m).

Authors:  Reza Alizadeh; Vahid Ziaee; Lotf-Ali Frooghifard; Mohammad-Ali Mansournia; Ziba Aghsaeifard
Journal:  Neurol Res Int       Date:  2012-03-19

5.  Acute mountain sickness, arterial oxygen saturation and heart rate among Tibetan students who reascend to Lhasa after 7 years at low altitude: a prospective cohort study.

Authors:  Espen Bjertness; Tianyi Wu; Hein Stigum; Per Nafstad
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

Review 6.  Putative Role of Respiratory Muscle Training to Improve Endurance Performance in Hypoxia: A Review.

Authors:  Jesús Álvarez-Herms; Sonia Julià-Sánchez; Francisco Corbi; Adrian Odriozola-Martínez; Martin Burtscher
Journal:  Front Physiol       Date:  2019-01-15       Impact factor: 4.566

7.  AltitudeOmics: the integrative physiology of human acclimatization to hypobaric hypoxia and its retention upon reascent.

Authors:  Andrew W Subudhi; Nicolas Bourdillon; Jenna Bucher; Christopher Davis; Jonathan E Elliott; Morgan Eutermoster; Oghenero Evero; Jui-Lin Fan; Sonja Jameson-Van Houten; Colleen G Julian; Jonathan Kark; Sherri Kark; Bengt Kayser; Julia P Kern; See Eun Kim; Corinna Lathan; Steven S Laurie; Andrew T Lovering; Ryan Paterson; David M Polaner; Benjamin J Ryan; James L Spira; Jack W Tsao; Nadine B Wachsmuth; Robert C Roach
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

8.  Acute mountain sickness among tourists visiting the high-altitude city of Lhasa at 3658 m above sea level: a cross-sectional study.

Authors:  Per Nafstad; Hein Stigum; Tianyi Wu; Øyvind Drejer Haldorsen; Kristoffer Ommundsen; Espen Bjertness
Journal:  Arch Public Health       Date:  2016-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.